Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis
- PMID: 35144744
- DOI: 10.1016/j.jacc.2021.11.042
Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis
Abstract
Background: Accurate estimation of low-density lipoprotein cholesterol (LDL-C) is important for guiding cholesterol-lowering therapy. Different methods currently exist to estimate LDL-C.
Objectives: This study sought to assess discordance of estimated LDL-C using the Friedewald, Sampson, and Martin/Hopkins equations.
Methods: Electronic health record data from patients with atherosclerotic cardiovascular disease and triglyceride (TG) levels of <400 mg/dL between October 1, 2015, and June 30, 2019, were retrospectively analyzed. LDL-C was estimated using the Friedewald, Sampson, and Martin/Hopkins equations. Patients were categorized as concordant if LDL-C was <70 mg/dL with each pairwise comparison of equations and as discordant if LDL-C was <70 mg/dL for the index equation and ≥70 mg/dL for the comparator.
Results: The study included 146,106 patients with atherosclerotic cardiovascular disease (mean age: 68 years; 56% male; 91% White). The Martin/Hopkins equation consistently estimated higher LDL-C values than the Friedewald and Sampson equations. Discordance rates were 15% for the Friedewald vs Martin/Hopkins comparison, 9% for the Friedewald vs Sampson comparison, and 7% for the Sampson vs Martin/Hopkins comparison. Discordance increased at lower LDL-C cutpoints and in those with elevated TG levels. Among patients with TG levels of ≥150 mg/dL, a >10 mg/dL difference in LDL-C was present in 67%, 27%, and 23% of patients when comparing the Friedewald vs Martin/Hopkins, Friedewald vs Sampson, and Sampson vs Martin/Hopkins equations, respectively.
Conclusions: Clinically meaningful differences in estimated LDL-C exist among equations, particularly at TG levels of ≥150 mg/dL and/or lower LDL-C levels. Reliance on the Friedewald and Sampson equations may result in the underestimation and undertreatment of LDL-C in those at increased risk.
Keywords: Friedewald equation; LDL-C; Martin/Hopkins equation; Sampson equation; atherosclerotic cardiovascular disease.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Virani has received grant support from the Department of Veterans Affairs, World Heart Federation, and Tahir and Jooma Family; and has received honorarium from the American College of Cardiology (as associate editor for Innovations, acc.org). Dr Martin has received research support from the American Heart Association, PCORI (Patient-Centered Outcomes Research Institute), National Institutes of Health, the David and June Trone Family Foundation, and Pollin Digital Health Innovation Fund; has served as a consultant for AstraZeneca, DalCor Pharmaceuticals, 89bio, Amgen, Esperion, iHealth, Kaneka, and Sanofi; has a patent pending for a system, of which he is a coinventor, to estimate low-density lipoprotein cholesterol levels; and is a founder of and holds equity in Corrie Health, which intends to further develop the platform. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
LDL-C Estimation: The Perils of Living With Imperfection.J Am Coll Cardiol. 2022 Feb 15;79(6):542-544. doi: 10.1016/j.jacc.2021.12.005. J Am Coll Cardiol. 2022. PMID: 35144745 No abstract available.
Similar articles
-
The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population.Lipids Health Dis. 2024 Jul 4;23(1):210. doi: 10.1186/s12944-024-02188-9. Lipids Health Dis. 2024. PMID: 38965543 Free PMC article.
-
Comparative performance of equations to estimate low-density lipoprotein cholesterol levels and cardiovascular disease incidence: The ATTICA study (2002-2022).Lipids. 2023 Jul;58(4):159-170. doi: 10.1002/lipd.12371. Epub 2023 May 8. Lipids. 2023. PMID: 37153959
-
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817. JAMA Netw Open. 2021. PMID: 34709388 Free PMC article.
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.Glob Heart. 2023 Jun 19;18(1):36. doi: 10.5334/gh.1214. eCollection 2023. Glob Heart. 2023. PMID: 37361322 Free PMC article.
-
Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations.Nutrients. 2023 May 5;15(9):2202. doi: 10.3390/nu15092202. Nutrients. 2023. PMID: 37432317 Free PMC article. Review.
Cited by
-
Efficacy and safety of proprotein convertase subtilisin kexin type (PCSK9) inhibitors in patients with acute coronary syndrome: A systematic review and meta-analysis.Medicine (Baltimore). 2024 May 31;103(22):e38360. doi: 10.1097/MD.0000000000038360. Medicine (Baltimore). 2024. PMID: 39259104 Free PMC article.
-
Quo vadis, LDL cholesterol?Adv Lab Med. 2023 May 31;4(2):133-137. doi: 10.1515/almed-2023-0051. eCollection 2023 Jun. Adv Lab Med. 2023. PMID: 38075940 Free PMC article. No abstract available.
-
Does LDL-C determination method affect statin prescribing for primary prevention? A register-based study in Southern Denmark.Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):500-504. doi: 10.1093/ehjcvp/pvae043. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38816214 Free PMC article.
-
Targeted drug delivery systems for atherosclerosis.J Nanobiotechnology. 2025 Apr 23;23(1):306. doi: 10.1186/s12951-025-03384-0. J Nanobiotechnology. 2025. PMID: 40269931 Free PMC article. Review.
-
The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population.Lipids Health Dis. 2024 Jul 4;23(1):210. doi: 10.1186/s12944-024-02188-9. Lipids Health Dis. 2024. PMID: 38965543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous